Zepp Health (ZEPP) Fundamentals 2026 — Revenue Analysis | SniperIQ
Zepp Health (ZEPP) is a NL-listed Technology company in Consumer Electronics with a market capitalization of $77M, trading at $5.41 on the NYSE. This SniperIQ fundamentals page covers Zepp Health's valuation, profitability (net margin -14.6%), revenue (¥1.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Zepp Health's market cap?
Zepp Health (ZEPP) has a market capitalization of approximately $77M, trading at $5.41 on the NYSE. Market cap moves with the live share price.
What is Zepp Health's P/E ratio?
Zepp Health's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.0x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is Zepp Health?
Zepp Health runs a net profit margin of -14.6%, a gross margin of 38.7%, and an operating margin of -10.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Zepp Health generate?
Zepp Health reported revenue of ¥1.8B for fiscal year 2025, with net income of -¥281M and earnings per share (EPS) of -283.04. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Zepp Health pay a dividend?
Zepp Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Zepp Health financially healthy?
Zepp Health carries a debt-to-equity ratio of 1.23x and a current ratio of 0.88x, with a market beta of 1.84. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Zepp Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Zepp Health (ZEPP) the key facts are: market cap $77M, revenue ¥1.8B, 52-week range 3.85-61.85. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.
Track Zepp Health's full fundamentals live
Get Zepp Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.